openPR Logo
Press release

Lawsuit filed for Investors in shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA)

07-21-2020 08:49 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares.

A lawsuit was filed on behalf of investors in Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) shares.

The Shareholders Foundation announced that an investor, who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA), filed a lawsuit over alleged violations of Federal Securities Laws by Verrica Pharmaceuticals Inc..

Investors who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) have certain options and for certain investors are short and strict deadlines running. Deadline: September 14, 2020. NASDAQ: VRCA investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

West Chester, PA based Verrica Pharmaceuticals Inc., a clinical stage medical dermatology company, develops and commercializes dermatological treatments in the United States. On June 29, 2020, Verrica Pharmaceuticals Inc disclosed receipt of a letter from the U.S. Food and Drug Administration ("FDA") regarding the Company's New Drug Application ("NDA") for VP-102 for the treatment of molluscum contagiosum. The letter identified certain deficiencies that preclude discussion of labeling and post-marketing requirements. Moreover, according to Verrica Pharmaceuticals Inc, the FDA's information requests have included "a specific request related to a potential safety issue with the applicator that could arise if the instructions for use were not properly followed."
Shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) declined from $16.00 per share on June 24, 2020, to as low as $7.65 per share on July 14, 2020.

The plaintiff claims that between September 16, 2019 and June 29, 2020, the defendants failed to disclose to investors that the Company’s proprietary applicator used for VP-102 posed certain safety risks if the instructions were not properly followed that, as a result, Verrica would incorporate certain user features to mitigate the safety risk, that the addition of the user feature would require additional testing for stability supportive data, that, as a result of the foregoing, regulatory approval for VP-102 was reasonably likely to be delayed, and that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) have certain options and should contact the Shareholders Foundation.

Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) here

News-ID: 2094347 • Views: 356

More Releases from Shareholders Foundation

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) Investor Alert: Investigation over pot …
An investigation was announced over potential breaches of fiduciary duties by certain directors at Vanda Pharmaceuticals Inc. (NASDAQ: VNDA. Investors who purchased shares of Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) and currently hold any of those Vanda Pharmaceuticals Inc. (NASDAQ: VNDA shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Vanda Pharmaceuticals Inc. (NASDAQ: VNDA
Investigation announced for Long-Term Investors in shares of Milestone Pharmaceu …
Certain directors of Milestone Pharmaceuticals Inc. are under investigation over potential breaches of fiduciary duties. Investors who purchased shares of Milestone Pharmaceuticals Inc. (NASDAQ: MIST) and currently hold any of those NASDAQ: MIST shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain Milestone Pharmaceuticals directors breached their fiduciary duties and caused damage to the
Investigation announced for Long-Term Investors in shares of iQIYI, Inc. (NASDAQ …
An investigation was announced for investors in shares of iQIYI, Inc. (NASDAQ: IQ) concerning potential breaches of fiduciary duties by certain directors and officers of iQIYI, Inc.. Investors who are current long term investors in iQIYI, Inc. (NASDAQ: IQ) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: IQ
Investigation announced for Investors in shares of Noble Energy, Inc. (NASDAQ: N …
An investigation was announced concerning whether the takeover of Noble Energy, Inc.is unfair to: NBL stockholders. Investors who purchased shares of Noble Energy, Inc. (NASDAQ: NBL) and currently hold any of those NASDAQ: NBL shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm concerns whether certain officers and directors of Noble Energy, Inc. breached their fiduciary duties

All 5 Releases


More Releases for Verrica

Global Poxviridae Infections Drug Market 2018 -Bavarian Nordic A/S, BioFactura, …
Apex Market Reports, recently published a detailed market research study focused on the “ Poxviridae Infections Drug Market” across the global, regional and country level. The report provides 360° analysis of “ Poxviridae Infections Drug Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend